BFIM
MEDP icon

Beese Fulmer Investment Management’s Medpace MEDP Stock Holding History

Beese Fulmer Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-759
Closed -$364K – 461
2026
Q1 		$364K Sell
759
-57
-7% -$29.2K 0.02% 266
2025
Q4 		$458K Buy
+816
New +$463K 0.03% 209

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Beese Fulmer Investment Management's MEDP Position: Q2 2026 in Review

Beese Fulmer Investment Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 759 shares — an estimated $364K sold.

Beese Fulmer Investment Management first reported a position in MEDP in Q4 2025 and held it in 2 quarters. The position peaked at $458K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Beese Fulmer Investment Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Beese Fulmer Investment Management sold 759 Medpace shares in Q2 2026, an estimated $364K.
  • Beese Fulmer Investment Management first reported a position in Medpace in Q4 2025 and held it in 2 quarters.
  • Beese Fulmer Investment Management's Medpace position peaked at $458K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.